Clinical Trials
Institution: Stanford University
Type: Individual Site
Purpose:
The purpose of this study is to compare the effectiveness and the safety of sarilumab in patients with glucocorticoid-dependent sarcoidosis. To demonstrate that sarilumab treatment will be effective for inducing and maintaining glucocorticoid-free remission in male or female patients with biopsy proven active, glucocorticoid-dependent sarcoidosis affecting the lungs, lymph nodes, liver, kidneys, spleen, bone, soft tissues, skin, and/or eyes.
Dates: September 5, 2019 - July 1, 2025
Disease: Pulmonary Fibrosis
Register:
https://clinicaltrials.gov/ct2/show/NCT04008069?term=sarilumab&cond=Sarcoidosis&rank=1
Contact:
Matthew Baker
541-760-8182
[email protected]
Page last updated: November 17, 2022
